Immunotherapy & Precision Immuno-Oncology

The Future of Cancer Treatment

While traditional methods for treating cancer, including chemotherapy and radiation, are often effective at killing cancer cells, they can also kill healthy cells, as well. Cancer researchers around the world are searching for more effective therapies that do not compromise patients' long-term health and wellness. One of the most promising research areas is immunotherapy, which has shown great promise in treating many types of cancer.

Immunotherapies, including immune checkpoint modulators and cell therapy, have revolutionized the treatment of many human diseases. Immunotherapy for cancer has improved the outcomes of many cancers to a level thought impossible even a few years ago and comprise a new family of treatments that are quickly becoming a foundation of modern medicine. Classic immunotherapies such as vaccines are becoming increasingly important in a world threatened by emerging pathogens and antibodies that target discrete molecules have helped patients control various autoimmune ailments. We leverage immunogenomics in personalized cancer treatment for each patient.

The Center for Immunotherapy & Precision Immuno-Oncology (CITI) is a state-of-the-art center dedicated to immunotherapy research, discovery and developmental therapeutics, with the ultimate goal to make precision immuno-oncology available for every patient. Learn more about our mission and goals.